$167.61
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

ICON plc operates as a clinical research organization, which engages in the provision of outsourced development services to the pharmaceutical, biotechnology, and medical device industries. The firm is engaged in providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. The company offers a range of specialized services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. The firm's services include clinical research services, commercial positioning, consulting, early phase, strategic solutions, laboratories, language services, medical imaging, real world intelligence, site and patient solutions, COVID-19 clinical operation and decentralized and hybrid clinical solutions. The company also provides its full range of clinical, consulting and commercial services across several sectors, which include biosimilars, biotechnology, government and public health solutions, medical devices and pharmaceuticals.
Country

IE

CEO

Mr. Barry Balfe

IPO date

1998

Employees

39,800

ISIN

IE0005711209

Key stats

Open

$166.00

Volume

653.83K

Market cap

$12.67B

Prev. close

$165.47

Impl / hst vl

-

Open interest

$0.00

$164.42

Day’s Range

$170.40

$66.57

52W Range

$203.91

Valuation

44
Valuation score
Fairly Valued
P/E
69.23
P/S
1.50
P/B
1.34
Current ratio
1.14
Debt / Equity
0.28
ROE
1.93%
Gross margin
23.58%
Income growth
-195.11%
FCF growth
-22.08

Analysts estimates

Consensus rating
Buy

The average rating from top 11 analysts indicates that stock is expected to perform in line with the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$184.62
The top 19 analysts forecasts that 12-month price may increase by 10.15%, with a low of $151.50 and a high of $231.00
$151.50
Low
$184.62
Avg
$231.00
High
Current price

Earnings

Q1 ‘26 revenue
$2.03B
Q1 ‘26 net income
$104.75M
Revenue
Net income
Previous EPS
$2.50
Estimate EPS
$2.60
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply